Yeo CM, Chong VH, Earnest A, Yang WL. Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World J Hepatol 2013; 5(5): 275-280 [PMID: 23717738 DOI: 10.4254/wjh.v5.i5.275]
Corresponding Author of This Article
Dr. Chong Meng Yeo, Department of Gastroenterology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. email@example.com
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Chong Meng Yeo, Wei Lyn Yang, Department of Gastroenterology, Tan Tock Seng Hospital, Singapore 308433, Singapore
Vui Heng Chong, Department of Medicine, RIPAS Hospital, Bandar Seri Begawan BA 1710, Brunei Darussalam
Arul Earnest, Clinical Research Unit, Tan Tock Seng Hospital, Singapore 308433, Singapore
Author contributions: Yeo CM and Yang WL conceived the idea of the study; Yeo CM collected that data; Chong VH and Earnest A analysed the data; Yeo CM and Chong VH wrote the manuscript; all authors read and approved the final manuscript; Yeo CM was the guarantor.
Correspondence to: Dr. Chong Meng Yeo, Department of Gastroenterology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. firstname.lastname@example.org
Telephone: +65-693577897 Fax: +65-63573087
Received: February 6, 2013 Revised: April 1, 2013 Accepted: May 7, 2013 Published online: May 27, 2013
Core tip: Old studies have shown that the prevalence of methotrexate (MTX) associated liver fibrosis and cirrhosis to be as high as 50% and 26% respectively. Later studies have shown that the risk is much lower than previously reported. These studies have been based on western patients. To date, there is no study that had assessed MTX hepatotoxicity in Asian patient based on liver histology. This study showed that the risk of methotrexate hepatoxicity in Asian patients with psoriasis is also low and progression is minimal. We showed that ethnicity and presence of diabetes and hyperlipidemia, part of the metabolic syndrome may be important factors.